GHM Filariasis IgG/IgM Rapid Test US – Dual-Target Qualitative Detection of Filarial IgG & IgM Antibodies with 15-Minute Results, Whole Blood / Serum / Plasma Sample Compatibility, and Professional Point-of-Care Use

SKU: GHM Filariasis IgG/IgM Rapid Test US
Brand: Global Healthcare Medical

Product Overview

Global Healthcare Medical GHM Filariasis IgG/IgM Rapid Test US is a lateral flow immunochromatographic assay designed for the qualitative detection and differentiation of IgG and IgM antibodies to lymphatic filarial parasites (Wuchereria bancrofti and Brugia malayi) in human whole blood, serum, or plasma specimens. The kit is intended for use by healthcare professionals as a screening test and as an aid in the diagnosis of lymphatic filariasis infection.

Lymphatic filariasis (LF), commonly known as elephantiasis, is a neglected tropical disease caused by parasitic nematodes transmitted through the bites of infected mosquitoes. The disease remains a significant public health challenge in many endemic countries, with over 657 million people in 39 countries worldwide threatened by lymphatic filariasis and requiring preventive chemotherapy to stop the spread of this parasitic infection. Globally, an estimated 129 million people were infected with LF, of which 43 million had clinical disease, including 25 million men with hydrocele and over 15 million people with lymphoedema. India bears the highest LF burden globally, accounting for approximately 62% (404.3 million) of the at-risk population.

The definitive parasitologic diagnosis is the demonstration of microfilariae in blood samples. However, this gold standard test is restricted by the requirement for nocturnal blood collection and lack of adequate sensitivity. Antibody detection provides an early means to detect filarial parasite infection. The presence of IgM to the parasite antigens suggests current infection, whereas IgG corresponds to late-stage infection or past infection. The GHM Filariasis IgG/IgM Rapid Test uses conserved recombinant antigens to simultaneously detect antibodies to both W. bancrofti and B. malayi parasites without the restriction on specimen collection timing.

The GHM Filariasis IgG/IgM Rapid Test US delivers qualitative results in just 15 minutes, supporting rapid clinical decision-making at the point of care. The test is compatible with whole blood (venipuncture or fingerstick), serum, and plasma specimens, providing flexible sample collection options suitable for a wide range of clinical settings, including decentralized and resource-limited environments where laboratory infrastructure may be limited.

The kit is intended for in vitro diagnostic use and professional use only, suitable for application scenarios including physician office laboratories, hospital laboratories, public health screening programs in endemic areas, tropical medicine clinics, and clinical laboratories. The VivaDiag product line is manufactured under an EN ISO 13485 certified quality management system covering in vitro diagnostic test kits and analyzers based on immunochromatography.

Key Features & Benefits

2-in-1 Detection – IgG and IgM in One Test

The GHM Filariasis IgG/IgM Rapid Test US utilizes a lateral flow immunochromatographic assay capable of simultaneously detecting and differentiating filarial IgG and IgM antibodies from a single patient sample. The test incorporates separate test lines for IgG and IgM, enabling clear differentiation between current/recent infection and past or chronic exposure in a single assay. This dual-target design provides a comprehensive diagnostic picture that supports appropriate clinical decision-making and effective patient management.

Fast Results – 15 Minutes

The GHM Filariasis IgG/IgM Rapid Test US provides qualitative results in just 15 minutes, supporting rapid clinical decision-making and efficient patient workflow in point-of-care settings. Rapid diagnostic tests for filariasis enable faster case identification and support timely public health intervention in endemic areas.

Whole Blood / Serum / Plasma Compatibility – Flexible Sample Collection

The GHM Filariasis IgG/IgM Rapid Test US is compatible with whole blood (venipuncture or fingerstick), serum, and plasma specimens, providing flexible sample collection options to accommodate different clinical protocols and patient needs. Unlike traditional parasitological diagnosis that requires nocturnal blood collection, this antibody-based test can be performed at any time of day, overcoming a major barrier to filariasis diagnosis in field settings. The test requires only a small sample volume, making it suitable for both clinic-based and field-based testing scenarios.

Clinical Utility – Aid for Diagnosis of Lymphatic Filariasis

The GHM Filariasis IgG/IgM Rapid Test US is intended for use as a screening test and as an aid in the diagnosis of infection with lymphatic filarial parasites. The test provides rapid serological diagnosis, enabling timely clinical decision-making and supporting patient management. Early and accurate identification of filarial infection is essential for reducing LF-related morbidity and preventing disease progression to chronic lymphedema and hydrocele.

The dual-target design provides comprehensive diagnostic value. IgM antibodies typically indicate recent or current infection, while IgG antibodies reflect past or ongoing exposure to filarial parasites. The test is particularly valuable in settings where rapid identification of filarial infection supports public health surveillance and mass drug administration (MDA) program monitoring. The WHO has set a goal of eliminating LF by 2030 as a public health problem, and robust diagnostic tools are critical to achieving this target.

High Accuracy – Trusted Clinical Performance

The GHM Filariasis IgG/IgM Rapid Test US is designed to deliver reliable clinical performance with high sensitivity and specificity for both IgG and IgM targets. Published evaluations of rapid filariasis antibody tests have demonstrated excellent diagnostic accuracy.

Performance characteristics based on published evaluations of rapid filariasis antibody tests. A study conducted in the Kamwenge District, Western Uganda, using the Abbexa Filariasis IgG/IgM Rapid Test reported a sensitivity of 92.3% for IgG and 98.5% for IgM, with a specificity of 100% for both IgG and IgM, indicating a high level of reliability in detecting both positive and negative cases. Independent evaluations of the BLF Rapid™ test showed 100% diagnostic sensitivity and specificity in in-house evaluations, with 84–100% diagnostic sensitivity and 100% specificity in independent evaluations (excluding non-lymphatic filarial infections).

ISO 13485 Certified – Quality and Safety Compliance

The VivaDiag product line is manufactured under an EN ISO 13485 certified quality management system, demonstrating compliance with stringent international standards for the design, development, manufacture, and distribution of in vitro diagnostic test kits and analyzers.

CE Marked – European Conformity

The GHM Filariasis IgG/IgM Rapid Test US is CE marked for professional in vitro diagnostic use, demonstrating conformity with applicable European regulatory requirements for diagnostic medical devices.

Product Specifications

Why Clinical Professionals Choose Global Healthcare Medical

About Global Healthcare Medical

Global Healthcare Medical is dedicated to connecting healthcare providers, retailers, and distributors with high-quality medical devices designed for reliable performance. The GHM Filariasis IgG/IgM Rapid Test US is part of our professional diagnostic line, developed to support accurate, efficient, and accessible point-of-care testing in clinical environments.

Our focus is on dependable performance, clear documentation, and responsive support for professional healthcare settings.